Skip to main content
Log in

Nanosuspensions of 10-hydroxycamptothecin that can maintain high and extended supersaturation to enhance oral absorption: preparation, characterization and in vitro/in vivo evaluation

  • Research Paper
  • Published:
Journal of Nanoparticle Research Aims and scope Submit manuscript

Abstract

The purpose of the study was to prepare and characterize nanosuspensions that can maintain high and extended supersaturation to improve the dissolution and absorption of poorly soluble 10-hydroxycamptothecin (10-HCPT). 10-HCPT oral nanosuspensions (HCPT-Nanosuspensions) were produced on a laboratory-scale by microprecipitation- high pressure homogenization method. The particle morphology and the physical state were studied using transmission electron microscopy, X-ray powder diffraction (XRPD), and differential scanning calorimetry (DSC). Supersaturated dissolution tests were carried out with the paddle method. Caco-2 cell experiments were performed to imitate the oral absorption. The in vivo pharmacokinetics studies were undertaken in rats following oral administration. The 10-HCPT nanoparticles were 135 nm in dimension before lyophilization and were claviform or lump in shape. XRPD and DSC both confirmed that a portion of 10-HCPT was present in a crystalline state in nanosuspension. Supersaturated dissolution tests showed HCPT-Nanosuspensions could maintain high supersaturated level for an extended period time. The cell experiment on HCPT-Nanosuspensions showed a significantly higher uptake and greater membrane permeability compared with the other formulations. The pharmacokinetic test exhibited HCPT-Nanosuspensions had a similar pharmacokinetic performance with 10-HCPT solution. In conclusion, highly and extendedly supersaturated HCPT-Nanosuspensions have been prepared which could result in high peak concentration (C max) and great exposure (AUC) after oral administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Bittner B, Guenzi A, Fullhardt P, Zuercher G, Gonzalez RC, Mountfield RJ (2002) Improvement of the bioavailability of colchicine in rats by co-administration of D-alpha-tocopherol polyethylene glycol 1000 succinate and a polyethoxylated derivative of 12-hydroxy-stearic acid. Arzneimittelforschung 52(9):684–688

    CAS  Google Scholar 

  • Da Violante G, Zerrouk N, Richard I, Provot G, Chaumeil J, Arnaud P (2002) Evaluation of the cytotoxicity effect of dimethyl sulfoxide (DMSO) on Caco-2/TC7 colon tumor cell cultures. Biol Pharm Bull 25(12):4

    Article  Google Scholar 

  • Gao J, Hugger ED, Beck-Westermeyer MS, Borchardt RT (2000) Esimating intestinal permeation of compounds using Caco-2 cell monolayers. Wiley, New York, p 3

    Google Scholar 

  • Han R (1994) Highlight on the studies of anticancer drugs derived from plants in China. Stem Cells 12(1):53–63

    Article  CAS  Google Scholar 

  • Jacobs C, Müller RH (2002) Production and characterization of a budesonide nanosuspension for pulmonary administration. Pharm Res 19(2):189–194

    Article  CAS  Google Scholar 

  • Lenhardt T, Vergnault G, Grenier P, Scherer D, Langguth P (2008) Evaluation of nanosuspensions for absorption enhancement of poorly soluble drugs. In vitro transport studies across intestinal epithelial monolayers. AAPS J 10(3):435–438

    Article  CAS  Google Scholar 

  • Liversidge GG, Cundy KC (1995) Particle size reduction for improvement of oral bioavailability of hydrophobic drugs. I. Absolute oral bioavailability of nanocrystalline danazole in beagle dogs. Int J Pharm 125:91–97

    Article  CAS  Google Scholar 

  • Lu B, Zhang Z (2006) Novel colon-specific microspheres with highly dispersed hydroxycamptothecin cores: their preparation, release behavior, and therapeutic efficiency against colonic cancer. J Pharm Sci 95(12):2619–2630

    Article  CAS  Google Scholar 

  • Matteucci ME, Brettmann BK, Rogers TL, Elder EJ, Williams RO, I, Johnston KP (2007) Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media. Mol Pharm 4(5):782–793

  • Matteucci ME, Paguio JC, Miller MA, Williams RO, III, Johnston KP (2008) Highly supersaturated solutions of amorphous drugs approaching predictions from configurational thermodynamic properties. J Phys Chem B 112(51):16675–16681

  • Matteucci ME, Paguio JC, Miller MA, Williams RO, III, Johnston KP (2009) Highly supersaturated solutions from dissolution of amorphous itraconazole microparticles at pH 6.8. Mol Pharm 6(2):375–385

  • Müller RH, Peters K, Becker R, Kruss B (1995) Nanosuspensions—a novel formulation for the i.v. administration of poorly soluble drugs. 7th Int Conf on Pharm Technol (APV/APGI), pp 491–492

  • Müller RH, Peters K, Becker R, Kruss B (1995) Nanosuspensions for the i.v. administration of poorly soluble drugs- stability during sterilization and long-term storage. 22nd Int Symp Control Release Bioact. Mater, Seattle.

  • Peters K, Leitzke S, Diederichs JE, Borner K, Hahn H, Müller RH, Ehlers S (2000) Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection. J Antimicrob Chemother 45(1):77–83

    Article  CAS  Google Scholar 

  • Pignatello R, Bucolo C, Ferrara P, Maltese A, Puleo A, Puglisi G (2002) Eudragit RS10 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci 16:53–61

    Article  CAS  Google Scholar 

  • Prasad YV, Puthli SP, Eaimtrakarn S, Ishida M, Yoshikawa Y, Shibata N, Takada K (2003) Enhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in rats. Int J Pharm 250(1):181–190

    Article  CAS  Google Scholar 

  • Pu X, Sun J, Li M, He Z (2009a) Formulation of nanosuspensions as a new approach for the delivery of poorly soluble drugs. Curr Nanosci 5(4):417–427

    Article  CAS  Google Scholar 

  • Pu X, Sun J, Wang Y, Wang Y, Liu X, Zhang P, Tang X, Pan W, Han J, He Z (2009b) Development of a chemically stable 10-hydroxycamptothecin nanosuspensions. Int J Pharm 379(1):167–173

    Article  CAS  Google Scholar 

  • Pu X, Sun J, Zhang P, Wang Y, Sun Y, He Z (2011) Study on pharmacokinetics of HCPT nanosuspensions with ability of inhibiting P-gp in rats after oral administration. China J Chinese Materia Medica 36(14):1959–1963

    CAS  Google Scholar 

  • Sigfridsson K, Forssén S, Holländer P, Skantze U, de Verdier J (2007) A formulation comparison, using a solution and different nanosuspensions of a poorly soluble compound. Eur J Pharm Biopharm 67(2):540–547

    Article  CAS  Google Scholar 

  • Van Eerdenbrugh B, Froyen L, Martens JA, Blaton N, Augustijns P, Brewster M, Van den Mooter G (2007) Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze–dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling. Int J Pharm 338(1–2):198–206

    Article  Google Scholar 

  • Wacher VJ, Wong S, Wong HT (2002) Peppermint oil enhances cyclosporine oral bioavailability in rats: comparison with D-alpha-tocopheryl poly(ethylene glycol 1000) succinate (TPGS) and ketoconazole. J Pharm Sci 91(1):77–90

    Article  CAS  Google Scholar 

  • Wall ME, Wani MC, Cook CE, Palmer KH, McPhail AT, Sim GA (1966) Plant antitumor agent. 1. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from camptotheca acumianta. J Am Chem Soc 88(16):3888–3890

    Article  CAS  Google Scholar 

  • Collnot E, Baldes C, Schaefer U, Edgar K, Wempe M, Lehr CM (2010) Vitamin E TPGS P-glycoprotein inhibition mechanism influence: on conformational flexibility, intracellular ATP levels, and role of time and site of access. Mol Pharm 7(3):10

    Google Scholar 

  • Zhang R, Cai Q, Lindsey J, Li Y, Chambless B, Naguib F (1997) Antitumor activity and pharmacokinetics following oral administration of natural product DNA topoisomerase I inhibitors 10-hydroxycamptothecin and camptothecin in SCID mice bearing human breast cancer xenografts. Int J Oncol 10(6):1147–1156

    CAS  Google Scholar 

  • Zhang L, Sun M, Guo R, Jiang Z, Liu Y, Jiang X, Yang C (2006) Chitosan surface-modified hydroxycamptothecin loaded nanoparticles with enhanced transport across Caco-2 cell monolayer. J Nanosci Nanotechnol 6(9):2912–2920

    Article  CAS  Google Scholar 

  • Zhang Z, Tan S, Feng SS (2012) Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials 33(19):4889–4906

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge the support of this study by the National Natural Science Foundation of China (NSFC), No. 81173008 and the National Basic Research Program of China (973 program, 2009CB930300).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jin Sun or Zhonggui He.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pu, X., Sun, J., Han, J. et al. Nanosuspensions of 10-hydroxycamptothecin that can maintain high and extended supersaturation to enhance oral absorption: preparation, characterization and in vitro/in vivo evaluation. J Nanopart Res 15, 2043 (2013). https://doi.org/10.1007/s11051-013-2043-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11051-013-2043-1

Keywords

Navigation